JULY 2020 “ Host Genomics of COVID-19 ” study approved by UAB Institutional Review Board to provide genomic analysis of COVID-19 patients in Alabama
JUNE 2021 Enrollment launches at UAB Hospital-Highlands Family and Community Medicine
DECEMBER 2020
500 + biospecimens from COVID-19 patients shipped to the National Institutes of Health COVNET study , to identify common and rare germline genetic variants associated with susceptibility to severe or fatal COVID-19 disease
NOVEMBER 2021
National Organization for Rare Disorders ( NORD ) designates UAB Medicine and Children ’ s of Alabama as Rare Disease Centers of Excellence
2020 2021
SEPTEMBER 2020
Enrollment for whole genome sequencing resumes at Children ’ s Health Research Unit , operating under revised COVID-19 precautions
JULY 2021 HudsonAlpha Institute for Biotechnology and UAB ’ s collaborative participation in COVNET – a large , international genome-wide association study ( GWAS ) of COVID-19 severity – leads to discovery of an association with OAS1 genetic variants , affecting impaired viral clearance
JANUARY 2021 AGHI co-sponsors “ Rare Disease Symposium : Next- Generation Technology to Manage Rare Disease ”
DECEMBER 2021
DECEMBER 2021 Whole genome sequence enrollment expanded to include Children ’ s of Alabama and UAB NICU patients aghi . org 7